Developing Next-Generation TCR-T Therapies by CD8 Co-Expression
Time: 11:45 am
day: Day 2 - Track C - Morning
Details:
- Outlining next-gen approaches for TCR-engineered T-cell therapies for solid tumors
- Enhancement of anti-tumor immune responses through effective engagement of CD4 T cells
- Exploring the differential functional profiles of TCR-T cells co-expressing different types of CD8 co-receptors
